XML 45 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE LIABILITIES (Tables)
9 Months Ended
Dec. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
SCHEDULE OF FAIR VALUE OF EACH WARRANTS

 

     

Nine Months Ended

December 31, 2023

     

Nine Months Ended

December 31, 2022

 
Expected term     0.205.00 years       0.700.75 years  
Expected volatility     65- 327 %     113 - 172 %
Expected dividend yield     -       -  
Risk-free interest rate     3.605.55 %     4.644.73 %
Exercise price   $ 0.777 - 1.00       $1.00  
Market price     1.09 – $5.00       $0.40 - $1.43  
SCHEDULE OF REMAINING DERIVATIVE LIABILITIES

Derivative liabilities as of December 31, 2023 (unaudited) and March 31, 2023 are as follows.

 

   December 31, 2023   March 31, 2023 
    (unaudited)      
Fair value of Warrants issued in connection with Series C Preferred Stock (see Note 10)  $-   $9,948,473 
Fair value of conversion option on convertible notes payable (see Note 8)   -    534,898 
Total  $-   $10,483,371 
SCHEDULE OF ACTIVITY RELATED TO THE DERIVATIVE LIABILITIES

Activity related to the derivative liabilities for the nine months ended December 31, 2023 is as follows:

 

Beginning balance as of March 31, 2023  $10,483,371 
Issuances of Series C Warrants – derivative liabilities   3,263,470 
Issuance of Note 2 (see Note 8)   325,474 
Change in fair value of derivative liabilities   78,208,463 
Extinguishment of derivative liability upon repayment of convertible notes   (92,280,778)
Ending balance as of December 31, 2023  $-